Suchergebnisse - (ISNLINK:"1533-4406")

PubPharm (6)

1

Trastuzumab emtansine for residual invasive HER2-positive breast cancer

enthalten in: The New England journal of medicine | 2019

von Minckwitz, G. | Huang, C. | Mano, M. | +26

2

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

enthalten in: The New England journal of medicine | 2011

von Patel, M. | Mahaffey, K. | Garg, J. | +13

3

Combined C3b and factor B autoantibodies and MPGN type II

enthalten in: The New England journal of medicine | December 15, 2011

von Chen, Q. | Müller, D. | Rudolph, B. | +6

4

Desensitization of HLA-incompatible kidney recipients

enthalten in: The New England journal of medicine | October 27, 2011

von Morath, C. | Zeier, M. | Süsal, C.

5

Eculizumab for atypical hemolytic-uremic syndrome

enthalten in: The New England journal of medicine | January 29, 2009

von Nürnberger, J. | Philipp, T. | Witzke, O. | +8

6

High-dose atorvastatin after stroke or transient ischemic attack

enthalten in: The New England journal of medicine | August 10, 2006

von Amarenco, P. | Bogousslavsky, J. | Callahan, A. | +8

1
[1]